Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change
Consulting or advice, Fees or honoraria, 1 Oct 2026
Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial
Consulting or advice, 28 Aug 2026
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Grants or research support, 10 Oct 2022
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Grants or research support, 20 Aug 2021
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Grants or research support, 27 Jun 2021
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis
Consulting or advice, Fees or honoraria, Grants or research support, 1 Feb 2021